SCHLACKMAN SCOTT
SEC Form 4 insider trading activity
SCHLACKMAN SCOTT has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 28, 2026.
On the most recent filing, SCHLACKMAN SCOTT is listed as Director at MEDIFAST INC. Inside the rolling window, SCHLACKMAN SCOTT reported 2 open-market purchases totaling $63K in MED and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,500 MED shares on May 8, 2026, worth $32K.
Companies traded
Other insiders at MED
Insider Buying
$63K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SCHLACKMAN SCOTT made?
SCHLACKMAN SCOTT has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does SCHLACKMAN SCOTT trade?
SCHLACKMAN SCOTT has filed SEC Form 4 disclosures for 1 company, including MED.
When was SCHLACKMAN SCOTT's most recent SEC Form 4 filing?
SCHLACKMAN SCOTT's most recent SEC Form 4 filing on Tracefour is dated May 28, 2026.
What is SCHLACKMAN SCOTT's total buy and sell value in the current window?
Inside the rolling retention window, SCHLACKMAN SCOTT bought $63K and sold $0 based on SEC Form 4 filings.
What was SCHLACKMAN SCOTT's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,500 MED shares on 2026-05-08, worth $32K, per SEC Form 4 filings.